Apellis Pharmaceuticals, Inc.
USD41.03
+0.00 (+0.00%)
CEO
Cedric Francois
IPO Date
2017-11-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$41.05
Prev. Close
$41.03
Day Low
$41.03
Day High
$41.05
52W Low
$16.61
52W High
$41.14
Market Cap
$5.25B
Volume
28.64M
| 3,544 |
| $0.00 |
| 14 May 2026 | Dunlop A. Sinclair | director | D-Return | Disposed | 14,684 | $25.12 |
| 14 May 2026 | Dunlop A. Sinclair | director | D-Return | Disposed | 27,600 | $30.62 |
| 14 May 2026 | Dunlop A. Sinclair | director | D-Return | Disposed | 11,199 | $31.91 |
| 14 May 2026 | Dunlop A. Sinclair | director | D-Return | Disposed | 8,554 | $47.28 |
| 14 May 2026 | Dunlop A. Sinclair | director | D-Return | Disposed | 7,441 | $51.71 |
| 14 May 2026 | Dunlop A. Sinclair | director | D-Return | Disposed | 27,600 | $57.20 |
| 14 May 2026 | Dunlop A. Sinclair | director | D-Return | Disposed | 5,748 | $59.86 |
| 14 May 2026 | Chopas James George | VP/Chief Accounting Officer | U-Tender | Disposed | 65,955 | $0.00 |